Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Phase: N/A Priority: Normal
NCT ID: NCT06126224 Org: User:
Start: 08/28/23 End: 07/31/25 Due: 07/31/26

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Phase: N/A Priority: Normal
NCT ID: NCT05511363 Org: User:
Start: 08/23/22 End: 10/05/26 Due: 10/05/27

A Study to Evaluate the Effects of Lithium and Valproic Acid on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium and Valproic Acid in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06729970 Org: User:
Start: 12/26/24 End: 08/14/25 Due: 08/14/26

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)

Phase: N/A Priority: Normal
NCT ID: NCT04659161 Org: User:
Start: 12/16/20 End: 05/24/22 Due: 05/24/23

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Phase: N/A Priority: Normal
NCT ID: NCT05980949 Org: User:
Start: 07/11/23 End: 09/07/27 Due: 09/07/28

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Phase: N/A Priority: Normal
NCT ID: NCT06585787 Org: User:
Start: 09/26/24 End: 10/19/26 Due: 10/19/27

An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05643170 Org: User:
Start: 11/08/22 End: 03/08/23 Due: 03/08/24

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05304767 Org: User:
Start: 03/07/22 End: 03/19/26 Due: 03/19/27

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)

Phase: N/A Priority: Normal
NCT ID: NCT04738123 Org: User:
Start: 04/06/21 End: 12/07/22 Due: 12/07/23

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05145413 Org: User:
Start: 11/12/21 End: 03/19/25 Due: 03/19/26

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06605950 Org: User:
Start: 10/01/24 End: 05/31/25 Due: 05/31/26

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03697252 Org: User:
Start: 09/18/18 End: 09/04/19 Due: 09/04/20

Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06572449 Org: User:
Start: 10/28/24 End: 03/13/25 Due: 03/13/26

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

Phase: N/A Priority: Normal
NCT ID: NCT04820309 Org: User:
Start: 06/02/21 End: 05/24/24 Due: 05/24/25

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Phase: N/A Priority: Normal
NCT ID: NCT04659174 Org: User:
Start: 02/01/21 End: 10/03/23 Due: 10/03/24

A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05919823 Org: User:
Start: 05/29/23 End: 12/09/24 Due: 12/09/25

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

Phase: N/A Priority: Normal
NCT ID: NCT02831231 Org: User:
Start: 09/07/16 End: 10/28/16 Due: 10/28/17